A citrulline-containing decapeptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Poly Citrulline (acetate)

Item No. 44481

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(6S,9S,12S,15S,18S,21S,24S,27S,30S,33S)-1,6-diamino-1,7,10,13,16,19,22,25,28,31-decaoxo-9,12,15,18,21,24,27,30,33-nonakis(3-ureidopropyl)-2,8,11,14,17,20,23,26,29,32-decaazatetratriacontan-34-oic acid, acetate
Synonyms
  • Cit-Cit-Cit-Cit-Cit-Cit-Cit-Cit-Cit-Cit-OH
  • Decacitrulline
Molecular Formula
C60H112N30O21 • XC2H4O2
Formula Weight
1589.7
Purity
≥98%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(N[C@@H](CCCNC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=O)N
InChi Code
InChI=1S/C60H112N30O21/c61-31(11-1-21-72-51(62)102)41(91)82-32(12-2-22-73-52(63)103)42(92)83-33(13-3-23-74-53(64)104)43(93)84-34(14-4-24-75-54(65)105)44(94)85-35(15-5-25-76-55(66)106)45(95)86-36(16-6-26-77-56(67)107)46(96)87-37(17-7-27-78-57(68)108)47(97)88-38(18-8-28-79-58(69)109)48(98)89-39(19-9-29-80-59(70)110)49(99)90-40(50(100)101)20-10-30-81-60(71)111/h31-40H,1-30,61H2,(H,82,91)(H,83,92)(H,84,93)(H,85,94)(H,86,95)(H,87,96)(H,88,97)(H,89,98)(H,90,99)(H,100,101)(H3,62,72,102)(H3,63,73,103)(H3,64,74,104)(H3,65,75,105)(H3,66,76,106)(H3,67,77,107)(H3,68,78,108)(H3,69,79,109)(H3,70,80,110)(H3,71,81,111)/t31-,32-,33-,34-,35-,36-,37-,38-,39-,40-/m0/s1
InChi Key
IKILMDZFRBGSED-QMAXXTOWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $89

    Add

    5 mg

    $378

    Add
    Product Description

    Poly citrulline is a citrulline-containing decapeptide. It has been used as a hapten in the generation of anti-citrulline antibodies, which have been used to detect citrullination in postmortem human brain samples and synovial biopsy samples from patients with rheumatoid arthritis.1,2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nicholas, A.P., and Whitaker, J.N. Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain. Glia 37(4), 328-336 (2002).

    2. Makrygiannakis, D., Revu, S., Engström, M., et al. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis. Arthritis Res. Ther. 14(1), R20 (2012).